×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 2: How the Clinical Trial Regulation has Evolved
Session Chair(s)
Karina Griffiths
Director – Clinical Trial Application (CTA) Lead
Pfizer Ltd, United Kingdom
- Updates from Member States: General overview
- Feedback from pilots from selected European countries
- Sponsors perspective
- Ethics perspective
Speaker(s)
Karina Griffiths
Pfizer Ltd, United Kingdom
Director – Clinical Trial Application (CTA) Lead
Sini Eskola, MPharm, MS, MSc
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
Director Regulatory Affairs
Have an account?